The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment ... Aug. 22, 2024 — Managing hard ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

The Ministry of Public Health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...

When patients cannot adhere to inhaler instructions — whether because of cognitive or physical limitations — a nebulized LAMA might offer another method to safely deliver medication. To that end, GOLD ...

Nurses at Saint Vincent Hospital in Worcester allege that cost-saving measures are causing pervasive lapses in care, including two patients dying after failing to receive potentially life-saving ...